NNVC: NanoViricides Corp Company Aggregate Debts

NanoViricides, Inc. (NNVC) attracts rare biochemists through stock options to develop nanomedicines. However, the risk of scientific failure compared to mRNA technologies remains the primary challenge, which confirms the debt load status displayed on GURU.Markets; here 0.00 determines this parameter level. Simultaneously, the business competes for early-stage investments while avoiding direct price competition.

NanoViricides Inc. - NNVC Company Debts (period 07/04/2022 - 10/28/2026)

Analytical breakdowns and data insights for company NanoViricides, Inc. (NNVC)

- price and consensus price forecast:

Price Performance Chart nanoviricides.com|NNVC - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization NanoViricides Corp|NNVC - Total Company Value

- book capitalization data:

Accounting Value of a Share NanoViricides|NNVC - Company Book Value|Market Cap to Net Assets Ratio nanoviricides.com|NNVC - Company Total Assets

- debt and liquidity data:

Fundamental company analysis:NNVC NanoViricides Inc.

For long-term risk management, it is critical to track total credit obligations, which at the current value of 0.00 reflect the company's level of borrowed capital. By analyzing the overall state of obligations, an investor can see the liability dynamics of NanoViricides, Inc. (NNVC), allowing for an assessment of the nanocapsule developer's financial stability and its ability to fund scientific research without a critical debt load.

Key competitors